These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29596898)

  • 1. Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide.
    Costa A; Cristiano C; Cassano T; Gallelli CA; Gaetani S; Ghelardini C; Blandina P; Calignano A; Passani MB; Provensi G
    Neuropharmacology; 2018 Jun; 135():234-241. PubMed ID: 29596898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.
    Munari L; Provensi G; Passani MB; Galeotti N; Cassano T; Benetti F; Corradetti R; Blandina P
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv045. PubMed ID: 25899065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.
    Provensi G; Coccurello R; Umehara H; Munari L; Giacovazzo G; Galeotti N; Nosi D; Gaetani S; Romano A; Moles A; Blandina P; Passani MB
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11527-32. PubMed ID: 25049422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair.
    Yu HL; Sun LP; Li MM; Quan ZS
    Neurosci Lett; 2015 Apr; 593():24-8. PubMed ID: 25778418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.
    Umehara H; Fabbri R; Provensi G; Passani MB
    Pharmacol Res; 2016 Nov; 113(Pt A):100-107. PubMed ID: 27543461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress.
    Jin P; Yu HL; Tian-Lan ; Zhang F; Quan ZS
    Pharmacol Biochem Behav; 2015 Jun; 133():146-54. PubMed ID: 25864425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.
    Chen L; Li L; Chen J; Li L; Zheng Z; Ren J; Qiu Y
    Oncotarget; 2015 Dec; 6(40):42530-40. PubMed ID: 26729705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
    Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse.
    Provensi G; Costa A; Passani MB; Blandina P
    Neuropharmacology; 2016 Oct; 109():139-147. PubMed ID: 27291828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleoylethanolamide alleviates macrophage formation via AMPK/PPARα/STAT3 pathway.
    Zhao Y; Yan L; Peng L; Huang X; Zhang G; Chen B; Ren J; Zhou Y; Yang L; Peng L; Jin X; Wang Y
    Pharmacol Rep; 2018 Dec; 70(6):1185-1194. PubMed ID: 30336422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
    Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
    J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histaminergic Neurotransmission as a Gateway for the Cognitive Effect of Oleoylethanolamide in Contextual Fear Conditioning.
    Provensi G; Fabbri R; Munari L; Costa A; Baldi E; Bucherelli C; Blandina P; Passani MB
    Int J Neuropsychopharmacol; 2017 May; 20(5):392-399. PubMed ID: 28339575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
    Tutunchi H; Saghafi-Asl M; Ostadrahimi A
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
    Sihag J; Jones PJH
    Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.
    Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F
    Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleoylethanolamide-induced anorexia in rats is associated with locomotor impairment.
    Fedele S; Arnold M; Krieger JP; Wolfstädter B; Meyer U; Langhans W; Mansouri A
    Physiol Rep; 2018 Feb; 6(3):. PubMed ID: 29388342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism.
    Bilbao A; Blanco E; Luque-Rojas MJ; Suárez J; Palomino A; Vida M; Araos P; Bermúdez-Silva FJ; Fernández-Espejo E; Spanagel R; Rodríguez de Fonseca F
    Addict Biol; 2013 Jan; 18(1):78-87. PubMed ID: 23163925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells.
    Martínez de Ubago M; García-Oya I; Pérez-Pérez A; Canfrán-Duque A; Quintana-Portillo R; Rodríguez de Fonseca F; González-Yanes C; Sánchez-Margalet V
    Biochim Biophys Acta; 2009 Aug; 1791(8):740-5. PubMed ID: 19345745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
    Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the area postrema in the hypophagic effects of oleoylethanolamide.
    Romano A; Gallelli CA; Koczwara JB; Braegger FE; Vitalone A; Falchi M; Micioni Di Bonaventura MV; Cifani C; Cassano T; Lutz TA; Gaetani S
    Pharmacol Res; 2017 Aug; 122():20-34. PubMed ID: 28535974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.